ABCG2 and cancer: Indeed, it is reported that vemurafenib is a substrate of P-glycoprotein and BCRP (breast cancer resistance protein, ABCG2); therefore, ABCB1 overexpression in the cancer cells can simply avoid intracellular accumulation and activity of vemurafenib [48].